Author

Angelica A. Palm

Observed names: A Palm, A. Palm, Angelica A Palm, Angelica Palm

Institution: BioInvent (Sweden)

Observed institutions: Lund University, University of Oxford, BioInvent (Sweden)

ORCID: 0000-0002-4965-9370

Observed ORCID: 0000-0002-4965-9370

OpenAlex ID: A5009507427

Long-term follow-up of HIV-2-related AIDS and mortality in Guinea-Bissau: a prospective open cohort study

2018 · Joakim Esbjörnsson, Fredrik Månsson, et al. · The Lancet HIV · 98

Faster Progression to AIDS and AIDS-Related Death Among Seroincident Individuals Infected With Recombinant HIV-1 A3/CRF02_AG Compared With Sub-subtype A3

2013 · Angelica A. Palm, Joakim Esbjörnsson, et al. · The Journal of Infectious Diseases · 41

Essential genes shape cancer genomes through linear limitation of homozygous deletions

2019 · Maroulio Pertesi, Ludvig Ekdahl, et al. · Communications Biology · 19

Frequent Intratype Neutralization by Plasma Immunoglobulin A Identified in HIV Type 2 Infection

2012 · Gülşen Özkaya Şahin, Fredrik Månsson, et al. · AIDS Research and Human Retroviruses · 16

Interferon Alpha-Inducible Protein 27 Expression Is Linked to Disease Severity in Chronic Infection of Both HIV-1 and HIV-2

2022 · Angelica A. Palm, Srinivas Veerla, et al. · Frontiers in Virology · 11

Low Postseroconversion CD4 + T-cell Level Is Associated with Faster Disease Progression and Higher Viral Evolutionary Rate in HIV-2 Infection

2019 · Angelica A. Palm, Philippe Lemey, et al. · mBio · 8

Neutralizing Antibody Response and Antibody-Dependent Cellular Cytotoxicity in HIV-1–Infected Individuals from Guinea-Bissau and Denmark

2015 · Marie Borggren, Sanne Skov Jensen, et al. · AIDS Research and Human Retroviruses · 6

Cocirculation of Several Similar But Unique HIV-1 Recombinant Forms in Guinea-Bissau Revealed by Near Full-Length Genomic Sequencing

2015 · Angelica A. Palm, Joakim Esbjörnsson, et al. · AIDS Research and Human Retroviruses · 4

Distinct Plasma Protein Profiles Distinguish Faster from Slower Disease Progression in HIV-1 and HIV-2 infections

2024 · Emil Johansson, Jamirah Nazziwa, et al. · medRxiv · 3

Intra-Patient Evolution of HIV-2 Molecular Properties

2022 · Angelica A. Palm, Joakim Esbjörnsson, et al. · Viruses · 2

Intrahost evolution of the HIV-2 capsid correlates with progression to AIDS

2022 · M. T. Boswell, J. Nazziwa, et al. · Virus Evolution · 2

A “Function-First” Approach to Identify Regulatory T cell–Targeting Antibodies for Immunotherapy

2025 · Kirstie L.S. Cleary, Monika Semmrich, et al. · Cancer Immunology Research · 1

Data from A “Function-First” Approach to Identify Regulatory T cell–Targeting Antibodies for Immunotherapy

2025 · Kirstie L.S. Cleary, Monika Semmrich, et al.

Supplementary Figure S3 from A “Function-First” Approach to Identify Regulatory T cell–Targeting Antibodies for Immunotherapy

2025 · Kirstie L.S. Cleary, Monika Semmrich, et al.

Supplementary Figure S1 from A “Function-First” Approach to Identify Regulatory T cell–Targeting Antibodies for Immunotherapy

2025 · Kirstie L.S. Cleary, Monika Semmrich, et al.

Supplementary Figure S2 from A “Function-First” Approach to Identify Regulatory T cell–Targeting Antibodies for Immunotherapy

2025 · Kirstie L.S. Cleary, Monika Semmrich, et al.

Supplementary Table 5 from A “Function-First” Approach to Identify Regulatory T cell–Targeting Antibodies for Immunotherapy

2025 · Kirstie L.S. Cleary, Monika Semmrich, et al.

Supplementary Table 3 from A “Function-First” Approach to Identify Regulatory T cell–Targeting Antibodies for Immunotherapy

2025 · Kirstie L.S. Cleary, Monika Semmrich, et al.

Supplementary Table 1 from A “Function-First” Approach to Identify Regulatory T cell–Targeting Antibodies for Immunotherapy

2025 · Kirstie L.S. Cleary, Monika Semmrich, et al.

Supplementary Table 2 from A “Function-First” Approach to Identify Regulatory T cell–Targeting Antibodies for Immunotherapy

2025 · Kirstie L.S. Cleary, Monika Semmrich, et al.

Supplementary Table 4 from A “Function-First” Approach to Identify Regulatory T cell–Targeting Antibodies for Immunotherapy

2025 · Kirstie L.S. Cleary, Monika Semmrich, et al.

A17 The effect of intra-host evolution of HIV-2 capsid on disease progression

2019 · M T Boswell, A Palm, et al. · Virus Evolution

HIV disease progression - Impact of HIV-1 intersubtype recombination and association with HIV-2 evolution

2015 · Angelica A. Palm · Lund University Publications (Lund University)

Works count: 25

Citation count: 317

H-index: 8

I10-index: 6